Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new drug called GZR18 in healthy people. The goal is to see if the drug is safe and well-tolerated. Researchers will also study how the drug behaves in the body and its effects.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any prescription or non-prescription drugs, vitamins, or dietary/herbal supplements at least one week before the study drug is given and until the final follow-up visit.
Who Is on the Research Team?
Kimberly Lazaroff, MSN
Principal Investigator
Gan and Lee Pharmaceuticals, USA Corp
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single ascending dose of GZR18 or placebo via subcutaneous injection
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- GZR-18
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Gan and Lee Pharmaceuticals, USA
Lead Sponsor